132 related articles for article (PubMed ID: 1974237)
1. [Effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, on ischemic myocardial energy and carbohydrate metabolism in dogs].
Abe Y; Narimatsu A; Tobe A
Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):319-25. PubMed ID: 1974237
[TBL] [Abstract][Full Text] [Related]
2. Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
Abe Y; Ichihara K; Abiko Y
Biochem Pharmacol; 1991 Feb; 41(3):445-51. PubMed ID: 1825270
[TBL] [Abstract][Full Text] [Related]
3. Betaxolol, a cardioselective beta-adrenoceptor antagonist, attenuates ischemic myocardial acidosis in dogs.
Abe Y; Narimatsu A; Tobe A
Jpn J Pharmacol; 1990 Jun; 53(2):185-94. PubMed ID: 2385004
[TBL] [Abstract][Full Text] [Related]
4. [Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
Mizushima M
Hokkaido Igaku Zasshi; 1990 May; 65(3):298-310. PubMed ID: 2379912
[TBL] [Abstract][Full Text] [Related]
5. Effect of nadolol, a beta-adrenoceptor blocking agent, on myocardial metabolism in the dog ischaemic heart.
Ichihara K; Abiko Y
J Pharm Pharmacol; 1987 Aug; 39(8):604-8. PubMed ID: 2888850
[TBL] [Abstract][Full Text] [Related]
6. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Yoshida R; Ichihara K; Abiko Y
Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
[TBL] [Abstract][Full Text] [Related]
7. Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate.
Pieper GM; Gross GJ
Circulation; 1987 Oct; 76(4):916-28. PubMed ID: 2958176
[TBL] [Abstract][Full Text] [Related]
8. Effects of nipradilol, a new beta-adrenoceptor blocking agent with vasodilating properties, on transmural energy metabolism in the underperfused canine heart.
Higuchi M; Asakawa T
Jpn J Pharmacol; 1987 Jun; 44(2):145-53. PubMed ID: 2888916
[TBL] [Abstract][Full Text] [Related]
9. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.
Murry CE; Richard VJ; Reimer KA; Jennings RB
Circ Res; 1990 Apr; 66(4):913-31. PubMed ID: 2317895
[TBL] [Abstract][Full Text] [Related]
10. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
[TBL] [Abstract][Full Text] [Related]
11. Effects of LP-805, a newly developed vasodilator, on myocardial metabolism in ischaemic dog hearts.
Ichihara K; Morimoto T; Tsujitani M; Abiko Y
J Pharm Pharmacol; 1993 Feb; 45(2):131-6. PubMed ID: 8095528
[TBL] [Abstract][Full Text] [Related]
12. Effects of bunitrolol on ischemic myocardial energy metabolism in dogs.
Chiba K; Hayase N; Ichihara K
J Pharm Sci; 1993 Apr; 82(4):384-8. PubMed ID: 8096874
[TBL] [Abstract][Full Text] [Related]
13. Effect of flunarizine on ischemic myocardial metabolism in dogs.
Ichihara K; Maie S; Abiko Y
Eur J Pharmacol; 1989 Jun; 165(1):19-27. PubMed ID: 2767133
[TBL] [Abstract][Full Text] [Related]
14. Effects of tilisolol on ischemic myocardial metabolism in dogs.
Hayase N; Chiba K; Abiko Y; Ichihara K
Eur J Pharmacol; 1994 Aug; 260(2-3):183-90. PubMed ID: 7988643
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of nipradilol (K-351) on acute myocardial ischemia. Study of the relationship between regional myocardial blood flow and energy metabolism.
Okamoto Y; Matsubara T; Iyeda N; Miyajima K; Iida K; Nishida T; Kobayashi S; Kakinuma Y; Itoh K; Hibi N
Jpn J Pharmacol; 1990 Feb; 52(2):371-7. PubMed ID: 1968987
[TBL] [Abstract][Full Text] [Related]
16. Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion.
Puri PS; Varley KG; Kim SW; Barwinsky J; Cohen M; Dhalla NS
Am J Cardiol; 1975 Aug; 36(2):234-43. PubMed ID: 1080352
[TBL] [Abstract][Full Text] [Related]
17. Effects of amosulalol, a combined alpha 1- and beta-adrenoceptor-blocking agent, on ischemic myocardial energy metabolism in dogs.
Hayase N; Chiba K; Ichihara K
J Pharm Sci; 1993 Mar; 82(3):291-5. PubMed ID: 8095542
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts.
Kirimoto T; Nobori K; Asaka N; Muranaka Y; Tajima K; Miyake H
Arch Int Pharmacodyn Ther; 1996; 331(2):163-78. PubMed ID: 8937627
[TBL] [Abstract][Full Text] [Related]
19. Effects of betaxolol on cardiohemodynamics and coronary circulation in anesthetized dogs: comparison with atenolol and propranolol.
Satoh N; Suzuki J; Bessho H; Kitada Y; Narimatsu A; Tobe A
Jpn J Pharmacol; 1990 Oct; 54(2):113-9. PubMed ID: 2077180
[TBL] [Abstract][Full Text] [Related]
20. Effects of nebivolol on ischemia-induced metabolic changes in dog hearts.
Satoh K; Takeda S; Kaneta S; Inagami T; Ichihara K
J Cardiovasc Pharmacol; 2003 May; 41(5):766-70. PubMed ID: 12717108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
